Pulse Biosciences, Inc. (PLSE)
52.94
+4.14
(+8.50%)
USD |
NASDAQ |
Sep 09, 16:00
53.33
+0.40
(+0.75%)
After-Hours: 19:00
Pulse Biosciences Gross Profit Margin (Quarterly) : 37.10% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.10% |
| March 31, 2026 | 7.73% |
| December 31, 2025 | -96.59% |
| September 30, 2025 | -522.1% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 |
| Date | Value |
|---|---|
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -545.7% |
| March 31, 2022 | -178.2% |
| December 31, 2021 | -82.23% |
| September 30, 2021 | -73.17% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Accuray, Inc. | 34.76% |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 69.55% |
| ResMed, Inc. | 58.12% |
| Rockwell Medical, Inc. | 18.24% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.23% |
| Return on Assets | -76.64% |
| Return on Invested Capital | -83.18% |
| Profit Margin (Quarterly) | -5.68K% |
| Operating Margin (Quarterly) | -5.82K% |
| Return on Net Operating Assets | -747.1% |